VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,605 | -91.3% | 1,500 | -94.4% | 0.00% | – |
| Q2 2023 | $190,108 | -4.2% | 26,599 | +8.0% | 0.00% | – |
| Q1 2023 | $198,503 | +93.8% | 24,637 | +58.2% | 0.00% | – |
| Q4 2022 | $102,447 | -38.3% | 15,575 | -32.2% | 0.00% | – |
| Q2 2020 | $166,000 | -16.6% | 22,973 | -46.0% | 0.00% | -100.0% |
| Q1 2020 | $199,000 | -37.2% | 42,573 | +7.6% | 0.00% | 0.0% |
| Q4 2019 | $317,000 | +3.3% | 39,573 | -11.4% | 0.00% | 0.0% |
| Q3 2019 | $307,000 | -7.8% | 44,673 | +11.4% | 0.00% | 0.0% |
| Q2 2019 | $333,000 | -14.4% | 40,112 | +2.6% | 0.00% | 0.0% |
| Q1 2019 | $389,000 | +56.2% | 39,100 | +19.9% | 0.00% | 0.0% |
| Q4 2018 | $249,000 | -35.3% | 32,600 | -63.0% | 0.00% | -50.0% |
| Q1 2018 | $385,000 | +35.6% | 88,140 | +25.9% | 0.00% | +100.0% |
| Q4 2017 | $284,000 | +1394.7% | 70,000 | +600.0% | 0.00% | – |
| Q3 2017 | $19,000 | +90.0% | 10,000 | +233.3% | 0.00% | – |
| Q4 2015 | $10,000 | -44.4% | 3,000 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,720,000 | 3.11% |
| Sio Capital Management, LLC | 754,759 | $5,193,000 | 1.67% |
| APIS CAPITAL ADVISORS, LLC | 90,000 | $619,000 | 0.97% |
| KNOTT DAVID M | 218,102 | $1,501,000 | 0.63% |
| Park West Asset Management LLC | 1,747,507 | $12,023,000 | 0.59% |
| ArrowMark Colorado Holdings LLC | 8,131,528 | $55,945,000 | 0.56% |
| DAFNA Capital Management LLC | 209,200 | $1,439,000 | 0.54% |
| Rubric Capital Management LP | 660,000 | $4,541,000 | 0.42% |
| Rubric Capital Management LP | 500,000 | $3,440,000 | 0.32% |
| Cornerstone Capital, Inc. | 248,125 | $1,707,000 | 0.27% |